Reissig, F.; Bauer, D.; Zarschler, K.; Novy, Z.; Bendova, K.; Ludik, M.-C.; Kopka, K.; Pietzsch, H.-J.; Petrik, M.; Mamat, C.
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study. Cancers 2021, 13, 1974.
https://doi.org/10.3390/cancers13081974
AMA Style
Reissig F, Bauer D, Zarschler K, Novy Z, Bendova K, Ludik M-C, Kopka K, Pietzsch H-J, Petrik M, Mamat C.
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study. Cancers. 2021; 13(8):1974.
https://doi.org/10.3390/cancers13081974
Chicago/Turabian Style
Reissig, Falco, David Bauer, Kristof Zarschler, Zbynek Novy, Katerina Bendova, Marie-Charlotte Ludik, Klaus Kopka, Hans-Jürgen Pietzsch, Milos Petrik, and Constantin Mamat.
2021. "Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study" Cancers 13, no. 8: 1974.
https://doi.org/10.3390/cancers13081974
APA Style
Reissig, F., Bauer, D., Zarschler, K., Novy, Z., Bendova, K., Ludik, M.-C., Kopka, K., Pietzsch, H.-J., Petrik, M., & Mamat, C.
(2021). Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study. Cancers, 13(8), 1974.
https://doi.org/10.3390/cancers13081974
